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INTRODUCTION:  Therapeutic  mammoplasty  is used  in  the  treatment  of  suitably-sized  and  appropriately-
located  breast  cancers  to  achieve  adequate  cancer  excision,  resulting  in well-shaped  but smaller  breasts.
In patients  wishing  to maintain  or increase  their  breast  size,  simultaneous  augmentation  will be  required.
PRESENTATION  OF  CASE:  A  48-year-old  female  underwent  an  “augmentation-therapeutic  mastopexy”.  She
required  mastectomy  for  a multifocal  cancer  of  the  right  breast  and  breast  conservation  for  a  unifocal
localised  cancer  in  the  upper  part  of  the  left breast.  She  requested  right  immediate  breast  reconstruction
and  hoped  for  larger  breasts  than  she  had.  Due  to  complications  during  neoadjuvant  chemotherapy,
the right  reconstruction  plan  was changed  from  a deep  inferior  epigastric  perforator  (DIEP)  ﬂap  to  an
implant-based  technique.  On  the  left,  an  extended  superomedial  pedicle  therapeutic  mammoplasty  was
combined  with a subpectoral  augmentation  using  an  expandable-implant.
DISCUSSION:  The  use of expandable-implants  for reconstruction  of  partial  mastectomy  defects  in  com-
bination  with therapeutic  mammoplasty  has  not  been  reported.  This  case  report shows  that  such
“augmentation-therapeutic  mastopexy”  is feasible.
CONCLUSION:  A  “novel”  oncoplastic  technique  herein  termed  “augmentation-therapeutic  mastopexy”  is
described  for  partial  breast  reconstruction  during  the  treatment  of a  patient  with  bilateral  breast  cancer.
It enabled  adequate  treatment  of her cancer  while  reshaping  the  breast  and  achieving  the  desired  larger
breast size.  It should  be considered  in  selected  breast-conservation  patients  who  wish  to maintain  or
increase  their  breast  size.
© 2016  The  Authors.  Published  by Elsevier  Ltd  on  behalf  of IJS  Publishing  Group  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
Therapeutic mammoplasty is a well-established treatment
odality for suitably-sized and appropriately-located breast can-
ers. The Wise pattern is the most widely used mammoplasty
echnique for this purpose [1,2]. It is particularly suitable for
atients with large and/or ptotic breasts. Therapeutic mammo-
lasty results in smaller breasts because of the wide tumour
esection as well as the skin and gland resection necessary for
urgical closure. This is desirable in many patients as it improves
osmetic outcome, allows more uniform delivery of postoperative
adiotherapy (RT) and addresses macromastia symptoms [3]. The
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technique can be used in women  with smaller breasts to produce
a better shaped post-treatment breast, but some patients may ﬁnd
the resulting smaller breasts undesirable. Patients who wish to
maintain their breast volume may  therefore request simultaneous
augmentation of their breast.
Breast enlargement in this setting can be accomplished with
the use of ﬁxed-volume implants or expandable-implants (so
called “permanent expanders”). Although expandable-implants are
widely used in post-mastectomy immediate breast reconstruction
[4,5], their use has not been hitherto described for partial breast
reconstruction in combination with therapeutic mammoplasty.
We present a patient who  underwent such an “augmentation-
therapeutic mastopexy”, simultaneously treating her tumour
located superiorly above the nipple-areolar complex (NAC), and
achieving her desire to enlarge her pre-existing breast size.
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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aig. 1. Preoperative and 11-month postoperative photographs of the 48-year-old 
blique  views). Please note the prosthetic nipple on the mastectomy (right) side.
. Presentation of case
A 48-year-old female (Fig. 1) presented with a multifocal lobular
ancer of the right breast (requiring mastectomy) and a smaller
ocalised tubular carcinoma of the left breast. She requested right
mmediate breast reconstruction (IBR) and hoped for larger breasts
han she had. She was scheduled for bilateral mastectomies and
econstruction with deep inferior epigastric perforator (DIEP) ﬂaps.
uring neoadjuvant chemotherapy she lost signiﬁcant weight and
uptured a thoracic disc, making a DIEP ﬂap contraindicated. She
as offered expandable-implant and StratticeTM (porcine-derived
cellular dermal matrix (ADM)) reconstruction on the right, and at (BMI = 22, bra cup size = 34D, Grade II ptosis) (anteroposterior, left lateral, right
therapeutic mammoplasty with expanded-implant augmentation
on the left.
Bilateral Wise pattern skin reduction markings were made
prior to surgery (Fig. 2). A right mastectomy and level 2 axil-
lary clearance were performed (specimen weight = 398 g, skin
ellipse = 35 mm × 25 mm)  and a reconstruction undertaken with an
expandable-implant (nominal volume = 495–520 cm3) with 50 ml
of intraoperative saline ﬁll. The StratticeTM strip (10 cm × 16 cm)
was sutured to the inferolateral border of the pectoralis major mus-
cle and the inframammary fold to cover the inferolateral portion of
the expander.
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Fig. 2. Planned surgical incisions (Wise pattern) for the right mastectomy and left
therapeutic mammoplasty. Please note the nipple preservation on the left thera-
peutic mammoplasty side.
Fig. 3. Schematic diagram showing a left nipple-areola preserving Wise pattern





























Fig. 4. Intraoperative radiograph with wire and coil deployed conﬁrming the com-
pleteness of excision.
common symmetrising procedures following unilateral post-
mastectomy breast reconstruction [10]. Symmetrisation can be
undertaken as a primary or delayed procedure based on the patiention into the lumpectomy defect at 12 o’ clock.
A simultaneous left Wise pattern therapeutic mammoplasty
ith an extended superomedial pedicle (Fig. 3) was carried out
ith the extension transposed into the tumour excision defect.
he tumour located in the breast meridian superior to the nipple-
reolar complex (NAC) was widely excised with at least 1 cm
argins radially using the previously-deployed guide wires/coils
specimen weight = 16 g). The completeness of resection was  con-
rmed by intraoperative specimen radiographs (Fig. 4). A sentinel
ymph node biopsy was then performed through the breast incision.
ext, an expandable-implant (nominal volume = 295–315 cm3)
as inserted into the subpectoral pocket with 50 ml  of intraoper-
tive saline ﬁll. The wide local excision defect above the neo-NAC
osition was reconstructed by the transposition of superomedial
edicle extension and secured with interrupted 2/0 PDS. Glandu-
ar tissue rearrangement was achieved using 2/0 PDS. Both breasts
ere closed in a standard manner over suction drains.
Histological examination conﬁrmed complete disease excision
ilaterally and negative left sentinel lymph nodes. The patient
as reviewed regularly in clinic postoperatively and four weekly
xpander inﬂations yielded saline ﬁll volumes of 485 ml  (right) and
10 ml  (left). She received postoperative right chest wall and left
reast RT (40 Gy in 15 fractions with left tumour bed boost at 12 Gy
n 4 fractions). Her preoperative and 11 month postoperative (post-
T) appearances are shown in Fig. 1. Although she developed Grade
V capsular contracture secondary to RT despite the StratticeTM
DM support on the right (Fig. 1), there was no evidence of capsular
ontracture on the left therapeutic mammoplasty side (Fig. 5). The
ight breast was subsequently treated with a right free ﬂap salvage
fter a failed capsulectomy and implant exchange.Fig. 5. Severe soft tissue reaction to radiotherapy (12 days after its completion).
Note the prosthetic nipple in situ on the right.
3. Discussion
Most oncoplastic surgical techniques utilise breast parenchymal
rearrangements after full-thickness resections of skin and glandu-
lar tissue or employ established breast reduction or mastopexy
patterns to enable wide tumour resections while preserving or
enhancing the shape of the remaining breast [6]. This often neces-
sitates concomitant contralateral balancing surgery for optimal
symmetry [7]. 95% of patients undergoing immediate partial breast
reconstruction using therapeutic mammoplasty require a con-
tralateral breast reduction [8]. Other techniques employed include
mastopexy, breast augmentation, augmentation-mastopexy, and
mastectomy and bilateral immediate breast reconstruction (IBR)
[9]. Breast augmentation for contralateral balancing breast surgery
is indicated in patients with small breasts. It is, however, unre-
ported to augment a breast simultaneous with tumour treatment
by therapeutic mammoplasty and removal of the contralateral
breast by mastectomy with immediate prosthetic reconstruction.
3.1. The contralateral breast
Reduction mammoplasty and simple mastopexy are the mostand surgeon preference, and also patient selection [11,12]. It is
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arefully considered or withheld till margin status and the need
or further oncological survey is known [3]. This may  change the
ize and shape of the index breast, and one may  ﬁnd that the
reviously reduced breast now does not match the cancerous
reast. Additionally, the index breast will undergo postoperative
adiotherapy (RT), potentially increasing breast asymmetry if con-
ralateral symmetrisation is done as a primary procedure [1,13].
he irradiated (therapeutic mammoplasty) breast may become big-
er (due to chronic oedema from impaired lymphatic drainage) or
maller (consequent to RT-induced fat necrosis, ﬁbrosis and atro-
hy) [11]. In the Cambridge Breast Unit (CBU) it is preferred to
ndertake simultaneous contralateral breast reduction, as most
atients desire this and CBU’s radiation regimens have not found
adiation-induced breast shrinkage or ﬁbrosis to be a major prob-
em. The latter may  be because CBU routinely leaves the opposite
on-cancerous breast at least 10% bigger than the index breast,
imilar to the Emory University group’s recommendations [1].
Some patients may  have small and ptotic breasts and require
n augmentation-mastopexy. This procedure is complex [14] and
ess frequently utilised. Principal among the challenges is the difﬁ-
ulty in balancing the conﬂicting objectives of ideal augmentation
nd degree of breast lift. Without careful preoperative surgical exe-
ution, there is a high risk of recurrence of breast ptosis [15]. It is
herefore not surprising that augmentation-therapeutic mastopexy
as not been reported as simultaneous balancing surgery for con-
ralateral immediate prosthetic breast reconstruction. However,
he present case report shows that the technique can be success-
ully performed with good results.
Our patient posed a number of challenges. These included her
equest to have larger breasts than she had preoperatively, the
hemotherapy-induced complications precluding the use of an
bdominal ﬂap, and the requirement for postoperative RT.
.2. Postoperative radiotherapy effects on total and partial breast
econstruction
The need for postoperative bilateral RT in this patient was deter-
ined preoperatively using the Cambridge Radiotherapy Index
16]. RT can lead to ﬁbrosis, compromised skin and soft tissue qual-
ty, increased possibility of complications from reconstruction, and
 suboptimal aesthetic result [17]. Our patient demonstrated this on
he mastectomy side with the severe capsular contracture neces-
itating total capsulectomy and implant exchange. The RT-induced
issue damage was so severe that a few weeks after surgery, she
eveloped wound dehiscence and implant exposure culminating
n explantation. This has subsequently been successfully salvaged
y conversion to a totally autologous deep inferior epigastric per-
orator (DIEP) ﬂap [18].
Irradiating the reduced or uplifted breast presents a differ-
nt set of problems, notably fat necrosis, contraction or ﬁbrosis
f breast tissue and chronic lymphoedema of breast tissue and
kin (after therapeutic mammoplasty). It may  make the reduced
reast ﬁrmer [17], indurated and difﬁcult to shape later. Hence,
he MD  Anderson group prefers to perform the contralateral
alancing reduction sequentially, after RT [3]. Interestingly, our
atient did not develop any of these problems on the side of the
augmentation-therapeutic mastopexy” despite the severe RT reac-
ion on the side of the mastectomy, and the expandable-implant
ould be inﬂated satisfactorily. It was not feasible to undertake the
herapeutic mammoplasty at a later date as the patient had can-
er in this breast—the therapeutic mammoplasty was  being used
ot only for the symmetrisation purposes but also for the cancer
reatment.PEN  ACCESS
rgery Case Reports 23 (2016) 146–150 149
3.3. “Augmentation-therapeutic mastopexy”
Similar to therapeutic mammoplasties, the “augmentation-
therapeutic mastopexy” herein described is easy to incorporate into
the practice of surgeons who routinely perform cosmetic reduc-
tion mammoplasties and mastopexies. It is a useful addition to the
reconstructive armamentarium available for partial mastectomy
defects in women with suboptimal breast shapes who  also desire
an increase in their breast size.
4. Conclusion
Augmentation-mastopexy for cosmetic breast surgery is well-
established. It is, however, not been described for or in context
of partial breast reconstruction. It enables the enlargement of the
patient’s breasts while reshaping the breasts and adequately treat-
ing a suitably located breast cancer. “Augmentation-therapeutic
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